(Q7307897)

Regadenoson (English)

18 November 2016

chemical formula

C₁₅H₁₈N₈O₅

1 reference

Regadenoson (English)

18 November 2016

canonical SMILES

CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3C4C(C(C(O4)CO)O)O

1 reference

Regadenoson (English)

18 November 2016

isomeric SMILES

CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O

1 reference

Regadenoson (English)

parenteral route of administration

18 November 2016

defined daily dose

0.4 milligram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=C01EB21

active ingredient in

Rapiscan

1 reference

European Medicines Agency product number

EMEA/H/C/001176

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001176/human_med_001378.jsp

World Health Organisation international non-proprietary name

22 March 2017

Regadenoson (English)

1 reference

Regadenoson (English)

physically interacts with

19 January 2016

Adenosine A1 receptor

1 reference

17 August 2016

Adenosine A2a receptor

1 reference

17 August 2016

Adenosine A2b receptor

1 reference

17 August 2016

Adenosine A3 receptor

1 reference

imported from Wikimedia project

17 August 2016

pregnancy category

US pregnancy category C

1 reference

1 reference

https://www.pfizer.com/products/product-list

Commons category

Regadenoson

0 references

Identifiers

InChI

InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1

1 reference

Regadenoson (English)

LZPZPHGJDAGEJZ-AKAIJSEGSA-N

18 November 2016

InChIKey

2 references

Regadenoson (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

313348-27-5

2 references

Global Substance Registration System

UNII

7AXV542LZ4

regadenoson anhydrous (English)

LZPZPHGJDAGEJZ-AKAIJSEGSA-N

18 November 2016

InChIKey

10 April 2021

https://commonchemistry.cas.org/detail?cas_rn=313348-27-5

1 reference

Regadenoson (English)

18 November 2016

1 reference

Regadenoson (English)

18 November 2016

ChEBI ID

135613

mapping relation type

exact match

1 reference

ChEBI release 2019-10-02

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

REGADENOSON (English)

18 November 2016

1 reference

1 reference

DSSTOX compound identifier

DTXCID5031501

0 references

EC number

690-885-5

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.218.278

27 December 2018

ECHA Substance Infocard ID

1-{6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-2-yl}-N-methyl-1H-pyrazole-4-carboxamide (English)

quotation

CAS no.: 313348-27-5 (English)

100.218.278

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.218.278

27 December 2018

1-{6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-2-yl}-N-methyl-1H-pyrazole-4-carboxamide (English)

quotation

CAS no.: 313348-27-5 (English)

1 reference

Regadenoson (English)

publication date

17 November 2015

1 reference

regadenoson (English)

18 November 2016

regadenoson

0 references

RxNorm ID

1546015

1 reference

Global Substance Registration System

UNII

7AXV542LZ4

regadenoson anhydrous (English)

18 November 2016

1 reference

26 February 2018

1 reference

Global Substance Registration System

Regadenoson (English)

18 November 2016

1 reference

UNII

7AXV542LZ4

regadenoson anhydrous (English)

18 November 2016

1 reference

REGADENOSON (English)

19 January 2016

0 references

1 reference

1 reference

Regadenoson (English)